AI Science Tracker
EN

University of KwaZulu-Natal

1 discovery from 2026

Discoveries

Unsupervised machine learning identifies early stage breast cancer subclasses from aberrant glycogene expression and informs personalised drug treatment.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: GHSORM clustering of glycogene expression in 785 early-stage breast-cancer samples identified seven expression subclasses, and RFES selected 60 genes that classified the clusters with 90.48% accuracy on a held-out set. I-SPY2 pCR patterns are retrospective and exploratory; the study does not establish prospective treatment-selection benefit.

Technology: GHSORM clustering and random-forest feature selection

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
GHSORM hierarchical self-organizing-map clustering defines glycogene-expression subclasses; random-forest feature selection and classification predicts those subclasses.
Limitation / still unknown
The study evaluates the reported models and datasets only; broader generalization and real-world deployment outcomes were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s44371-026-01070-0

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.